Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ono Pharmaceutical CoOPHLF 74 FCF Margin % is 41.13% as of Mar. 2026, which is 145% above its 10-year median of 16.78. GuruFocus rates OPHLF with a GF Score™ of 74/100 and a GF Value™ of $12.88 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 963 Drug Manufacturers companies, Ono Pharmaceutical Co ranks better than 83.18% on this metric.
The historical rank and industry rank for Ono Pharmaceutical Co's FCF Margin % or its related term are showing as below:
OPHLF'
s FCF Margin % Range Over the Past 10 Years
Min: -5.39 Med: 16.78 Max: 32.45
Current: 15.42
During the past 13 years, the highest FCF Margin % of Ono Pharmaceutical Co was 32.45%. The lowest was -5.39%. And the median was 16.78%.
OPHLF's FCF Margin % is ranked better than 83.18% of 963
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs OPHLF: 15.42
Ono Pharmaceutical Co FCF Margin % Related Terms
Ono Pharmaceutical Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Ono Pharmaceutical Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Ono Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ono Pharmaceutical Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ono Pharmaceutical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Ono Pharmaceutical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ono Pharmaceutical Co (OPHLF) has a FCF Margin % of 41.13% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ono Pharmaceutical Co and its competitors. This is 145% above median its historical median of 16.78. According to the industry distribution chart, Ono Pharmaceutical Co ranks #162 out of 963 companies in the Drug Manufacturers industry, placing it in the top 16.8%.
Is Ono Pharmaceutical Co's FCF Margin % too high?
Ono Pharmaceutical Co's current FCF Margin % of 41.13% is 145% above median its 10-year median of 16.78. The Drug Manufacturers industry median FCF Margin % is 2.51. Ono Pharmaceutical Co's value of 41.13% is 1538.6% above this industry median. Based on the distribution chart, Ono Pharmaceutical Co ranks #162 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Ono Pharmaceutical Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Ono Pharmaceutical Co ranks #162 out of 963 companies for FCF Margin %. This places Ono Pharmaceutical Co in the top 17% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Ono Pharmaceutical Co's value of 41.13% is 1538.6% above this benchmark. While the company's 10-year median is 16.78 vs. the industry median of 2.51, Ono Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ono Pharmaceutical Co's current FCF Margin % of 41.13% is 1538.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ono Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ono Pharmaceutical Co's current FCF Margin % is 41.13%, which is 145% above median its own 10-year median of 16.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (OPHLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $12.88, compared to a current price of $14.90 — trading 15.7% above its estimated fair value. The current FCF Margin % is 41.13%, which is 145% above median its 10-year median of 16.78 and 1538.6% above the Drug Manufacturers industry median of 2.51. Ono Pharmaceutical Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ono Pharmaceutical Co (OPHLF), the current FCF Margin % is 41.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ono Pharmaceutical Co (OPHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued.
The current stock price of $14.90 is trading 15.7% above its estimated GF Value™ of $12.88.
GuruFocus considers Ono Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for OPHLF:
FCF Margin %: 41.13% (145% above median its 10-year median of 16.78)
GF Value™: $12.88 vs. price of $14.90 (15.7% above fair value)
Industry Position: 1538.6% above the Drug Manufacturers median (#162 of 963)
No single metric tells the full story. See the OPHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
74GF Score
Get the complete analysis for OPHLF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPHLF has been successfully added to your 
